BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35469998)

  • 1. Curcumin: A therapeutic strategy for targeting the Helicobacter pylori-related diseases.
    Mohammadi A; Khanbabaei H; Zandi F; Ahmadi A; Haftcheshmeh SM; Johnston TP; Sahebkar A
    Microb Pathog; 2022 May; 166():105552. PubMed ID: 35469998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.
    Sarkar A; De R; Mukhopadhyay AK
    World J Gastroenterol; 2016 Mar; 22(9):2736-48. PubMed ID: 26973412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antimicrobial activity of curcumin against Helicobacter pylori isolates from India and during infections in mice.
    De R; Kundu P; Swarnakar S; Ramamurthy T; Chowdhury A; Nair GB; Mukhopadhyay AK
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1592-7. PubMed ID: 19204190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-Decade Failure to the Eradication of Refractory
    Moghadam MT; Chegini Z; Norouzi A; Dousari AS; Shariati A
    Curr Pharm Biotechnol; 2021; 22(7):945-959. PubMed ID: 32767919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori Eradication to Eliminate Gastric Cancer: The Japanese Strategy.
    Asaka M; Mabe K; Matsushima R; Tsuda M
    Gastroenterol Clin North Am; 2015 Sep; 44(3):639-48. PubMed ID: 26314673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions.
    Sokic-Milutinovic A; Alempijevic T; Milosavljevic T
    World J Gastroenterol; 2015 Nov; 21(41):11654-72. PubMed ID: 26556993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Helicobacter pylori eradication for gastric cancer prevention.
    Cheung TK; Xia HH; Wong BC
    J Gastroenterol; 2007 Jan; 42 Suppl 17():10-5. PubMed ID: 17238019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Helicobacter pylori and prevention of gastric cancer.
    Cheung TK; Wong BC
    J Dig Dis; 2008 Feb; 9(1):8-13. PubMed ID: 18251788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimized diagnosis of
    Cho JH; Jin SY
    Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):553-564. PubMed ID: 32410515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of gastric cancer by Helicobacter pylori eradication.
    Leodolter A; Naumann M; Malfertheiner P
    Dig Dis; 2004; 22(4):313-9. PubMed ID: 15812153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-microbial and anti-inflammatory effects of Cheonwangbosim-dan against
    Park HS; Jeong HY; Kim YS; Seo CS; Ha H; Kwon HJ
    J Vet Sci; 2020 May; 21(3):e39. PubMed ID: 32476313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.
    Take S; Mizuno M; Ishiki K; Nagahara Y; Yoshida T; Yokota K; Oguma K
    J Gastroenterol; 2007 Jan; 42 Suppl 17():21-7. PubMed ID: 17238021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A curcumin-based 1-week triple therapy for eradication of Helicobacter pylori infection: something to learn from failure?
    Di Mario F; Cavallaro LG; Nouvenne A; Stefani N; Cavestro GM; Iori V; Maino M; Comparato G; Fanigliulo L; Morana E; Pilotto A; Martelli L; Martelli M; Leandro G; Franzè A
    Helicobacter; 2007 Jun; 12(3):238-43. PubMed ID: 17493004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the treatment of Helicobacter pylori infection].
    Tu S; Yang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Sep; 39(9):981-8. PubMed ID: 25269503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori eradication as a preventive tool against gastric cancer.
    Hamajima N; Goto Y; Nishio K; Tanaka D; Kawai S; Sakakibara H; Kondo T
    Asian Pac J Cancer Prev; 2004; 5(3):246-52. PubMed ID: 15373702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategy for the treatment of Helicobacter pylori infection.
    Shiota S; Yamaoka Y
    Curr Pharm Des; 2014; 20(28):4489-500. PubMed ID: 24180402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can gastric cancer be prevented by Helicobacter pylori eradication?
    Malfertheiner P; Fry LC; Mönkemüller K
    Best Pract Res Clin Gastroenterol; 2006; 20(4):709-19. PubMed ID: 16997155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Turmeric and curcumin as adjuncts in controlling Helicobacter pylori-associated diseases: a narrative review.
    Boyanova L; Medeiros J; Yordanov D; Gergova R; Markovska R
    Lett Appl Microbiol; 2024 Jun; 77(6):. PubMed ID: 38794899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Good bugs and bad bugs: indications and therapies for Helicobacter pylori eradication.
    Kuipers EJ; Janssen MJ; de Boer WA
    Curr Opin Pharmacol; 2003 Oct; 3(5):480-5. PubMed ID: 14559092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori eradication in the prevention of gastric cancer: are more trials needed?
    Park JY; Forman D; Greenberg ER; Herrero R
    Curr Oncol Rep; 2013 Dec; 15(6):517-25. PubMed ID: 24101366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.